CPT 29824: Arthroscopic Distal Clavicle Resection (Mumford Procedure)
Medicare pays $652 and commercial payers pay $2211 on average nationally for this procedure.
CPT code 29824 describes an arthroscopic distal clavicle resection (Mumford procedure) in which the provider uses an arthroscope and instruments to remove a portion of the clavicle to relieve pain from chronic inflammatory conditions, impingement, or bone spurs; service type: arthroscopic shoulder surgical procedure; typical site of service: hospital outpatient department or ambulatory surgical center.
For related coverage guidance, see recent payer policy updates: Dental Anesthesia Services, Anesthesia Services for Interventional Pain Management Procedures in an Adult, General Anesthesia and Conscious Sedation Services.
Customize your policy alerts
Sign up for cpt 29824 policy alerts
Get alerted when payer policies referencing 29824 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
Medicare’s national mean rate of $652.20 for CPT 29824 sits well below BUCA’s average commercial mean of $2,210.60, reflecting a substantial gap between federal program reimbursement and aggregated commercial pricing. That difference of $1,558.40 highlights how commercial arrangements — represented by BUCA here — tend to pay multiple times Medicare’s average for this arthroscopic knee procedure, with other major commercial payers’ means (e.g., Blue Cross Blue Shield $3,164.60; UnitedHealth Group $1,202.90; Cigna $1,125.60; Aetna $487.40) distributed around those endpoints.
Dispersion measured as the interquartile range (P75−P25) is widest for Blue Cross Blue Shield at $2,507.60 and narrowest for Aetna at $606.00, indicating BCBS has the largest middle-50% spread while Aetna’s middle range is relatively tight. UnitedHealth Group ($734.80) and BUCA ($1,731.60) show moderate dispersion, with Cigna’s IQR at $765.20; Medicare’s IQR is small at $59.00 based on available locality percentiles, reflecting relatively low variation across its localities compared with most commercial payers.